Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.06 USD | -3.47% | -4.08% | +7.75% |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 | |
04-17 | DiaMedica Therapeutics Launches Late-Stage Trial of Potential Stroke Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.75% | 120M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- Oppenheimer Adjusts DiaMedica Therapeutics PT to $17 From $21, Maintains Outperform Rating